Cytosorbents Corporation
CTSO
$0.8906
-$0.0225-2.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.95M | -1.48M | -7.88M | -2.33M | -4.30M |
| Total Depreciation and Amortization | 440.30K | 404.70K | 425.60K | 428.80K | 446.80K |
| Total Amortization of Deferred Charges | 190.60K | 190.40K | 190.40K | 190.40K | -10.70K |
| Total Other Non-Cash Items | -5.35M | -2.19M | 6.44M | -2.02M | 1.83M |
| Change in Net Operating Assets | 1.26M | -388.00K | -1.52M | 1.28M | -2.77M |
| Cash from Operations | -1.51M | -3.47M | -2.34M | -2.46M | -4.79M |
| Capital Expenditure | -36.90K | -2.10K | -69.20K | -151.70K | -17.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.90K | -45.10K | -55.00K | -146.60K | -101.20K |
| Cash from Investing | -131.80K | -47.20K | -124.20K | -298.40K | -119.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 15.00M |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -4.38M |
| Issuance of Common Stock | -- | 6.83M | 166.90K | -- | -- |
| Repurchase of Common Stock | -1.10K | -- | -- | -41.50K | -200.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -57.60K | -790.00K |
| Cash from Financing | -1.10K | 6.83M | 166.90K | -99.00K | 9.83M |
| Foreign Exchange rate Adjustments | 259.10K | 25.90K | -105.90K | 85.20K | -69.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.38M | 3.35M | -2.41M | -2.77M | 4.85M |